Literature DB >> 21256160

Induction of heme oxygenase-1 expression by cilostazol contributes to its anti-inflammatory effects in J774 murine macrophages.

So Youn Park1, Sung Won Lee, Seung Hoon Baek, Seung Jin Lee, Won Suk Lee, Byung Yong Rhim, Ki Whan Hong, Chi Dae Kim.   

Abstract

The effects of cilostazol on stimulating heme oxygenase (HO)-1 expression including signal pathways and suppression of inflammatory cytokines and molecules were studied. Cilostazol stimulation time (1-8 h)- and concentration (1-30 μM)-dependently increased the HO-1 mRNA and protein expression associated with increased HO-1 activity, as did cobalt protoporphyrin IX (1-3 μM) in J774 macrophages. In addition, cilostazol (1-30 μM) concentration-dependently reduced lipopolysaccharide (LPS)-mediated nitrite and TNF-α production, in accordance with the inhibition of LPS-stimulated inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expression in the J774 macrophages, as did CoPP (1 μM). In parallel with these results, LPS-induced IκBα degradation and NF-κB nuclear translocation were significantly decreased after treatment with cilostazol as well as with CoPP. These effects of cilostazol and CoPP were significantly reversed by Zn protoporphyrin IX (ZnPP). The effects of cilostazol on IκBα expression and nitrite production were not manifested in the cells transfected with HO-1 small interfering RNA. In the J774 macrophages, cilostazol time (0-180min)- and concentration (1-100μM)-dependently increased the nuclear expression of NF-E2 related factor (Nrf2) and antioxidant response element (ARE) activity (3.70±0.45 fold, P<0.01). PI3-kinase and Akt play a role in the major signal pathways with cilostazol-induced HO-1 expression. In summary, cilostazol suppressed production of anti-inflammatory cytokines and molecules via inhibition of NF-κB activation, through a mechanism involving up-regulation of cyclic AMP-dependent protein kinase activation-coupled Nrf2-linked HO-1 expression in J774A.1 macrophages.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256160     DOI: 10.1016/j.imlet.2011.01.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

Review 1.  Practical strategies for modulating foam cell formation and behavior.

Authors:  Elisabeth Uitz; Babak Bahadori; Mark F McCarty; Mohammed H Moghadasian
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

2.  Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis.

Authors:  Yingqing Chen; Indira Pandiri; Yeonsoo Joe; Hyo Jeong Kim; Seul-Ki Kim; Jeongmin Park; Jinhyun Ryu; Gyeong Jae Cho; Jeong Woo Park; Stefan W Ryter; Hun Taeg Chung
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

3.  The role of NFκB in spheroid formation of human breast cancer cells cultured on the Random Positioning Machine.

Authors:  Sascha Kopp; Jayashree Sahana; Tawhidul Islam; Asbjørn Graver Petersen; Johann Bauer; Thomas J Corydon; Herbert Schulz; Kathrin Saar; Norbert Huebner; Lasse Slumstrup; Stefan Riwaldt; Markus Wehland; Manfred Infanger; Ronald Luetzenberg; Daniela Grimm
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 4.  Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target.

Authors:  Nadia Alice Vieira Motta; Lis Jappour Autran; Stephani Correia Brazão; Rosane de Oliveira Lopes; Christianne Brêtas Vieira Scaramello; Gabriel Ferreira Lima; Fernanda Carla Ferreira de Brito
Journal:  Int Immunopharmacol       Date:  2020-12-28       Impact factor: 5.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.